Last Price
12.07
Today's Change
+0.82 (7.28%)
Day's Change
11.63 - 12.99
Trading Volume
16,311
Overview
Market Cap
39 Million
Shares Outstanding
3 Million
Avg Volume
44,935
Avg Price (50 Days)
11.20
Avg Price (200 Days)
10.09
PE Ratio
-0.71
EPS
-16.94
Earnings Announcement
20-Mar-2025
Previous Close
11.25
Open
12.13
Day's Range
11.63 - 12.99
Year Range
6.0 - 18.17
Trading Volume
16,311
Price Change Highlight
1 Day Change
7.29%
5 Day Change
0.58%
1 Month Change
-10.33%
3 Month Change
8.84%
6 Month Change
40.02%
Ytd Change
-15.30%
1 Year Change
54.74%
3 Year Change
-66.33%
5 Year Change
-92.04%
10 Year Change
-92.04%
Max Change
-92.04%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic for the treatment of severe liver disease; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are expressed in intestinal crypts. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
